Disclosure Of Income Tax [Text Block]

Egetis Therapeutics - Filing #5995613

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of income tax [text block]	—	NOT 16	—	—
Major components of tax expense (income) [abstract]
Tax expense (income)	—	3,000,000 SEK	—	1,000,000 SEK
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]	—	—	—	—
Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets and liabilities [abstract]
Deferred tax assets	6,000,000 SEK	—	- SEK	—
Deferred tax liabilities	5,000,000 SEK	—	- SEK	—
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]